A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Ranging Study of Oral RGT001-075 in Adult Patients With Uncontrollable Type 2 Diabetes Mellitus on Metformin Therapy
Latest Information Update: 23 Nov 2023
At a glance
- Drugs RGT 075 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Regor Therapeutics
Most Recent Events
- 14 Nov 2023 Status changed from recruiting to discontinued due to financial constraint.
- 12 Apr 2022 Status changed from not yet recruiting to recruiting.
- 31 Mar 2022 New trial record